SCHEMBL13348138

SCHEMBL13348138

O=CCCc1ccc(OCc2cccc3c2N(C(=O)c2ccccc2)CCC3)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPD P32754 3/20 0.41
PTGER4 P35408 2/20 0.41
PTGER2 P43116 2/20 0.41
TSHR P16473 4/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
GFER P55789 1/20 0.38
PAX8 Q06710 1/20 0.38
KLF5 Q13887 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13312059 0.89 RXRA (0.48) HPDPTGER4PTGER2TSHRALDH1A1
SCHEMBL13348240 0.85 PTGER2 (0.49) PTGER4PTGER2TSHRALDH1A1HPGD
SCHEMBL3501359 0.85 TSHR (0.41) HPDPTGER4PTGER2TSHRALDH1A1
SCHEMBL13348268 0.84 RXRA (0.51) PTGER4PTGER2POLBNPC1RAB9A
SCHEMBL13312462 0.84 FFAR1 (0.46) HPDPTGER4PTGER2NPC1RAB9A
SCHEMBL13348225 0.84 LTA4H (0.35) HPDPTGER4PTGER2PDCD1CD274
SCHEMBL13348407 0.83 FFAR1 (0.38) PTGER4PTGER2ALDH1A1HPGDPDCD1
SCHEMBL13348224 0.82 PTGER4 (0.46) PTGER4PTGER2
SCHEMBL13348107 0.81 PTGER4 (0.44) PTGER4PTGER2POLBNPC1RAB9A
SCHEMBL13348223 0.81 HRH3 (0.43) PTGER4PTGER2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 HPD 753/4885PTGER4 1432/4885PTGER2 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.